FMP
Novavax, Inc.
NVAX
NASDAQ
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
5.6 USD
-0.38 (-6.79%)
Earnings
Dividends
We are unable to load the chart at this time.
Splits
From:
To:
Date
Revenue
Earnings
Estimated Earnings
Surprise
2025-02-27
88.31M
-0.51
-0.75
-32.00%
2024-11-12
84.51M
-0.76
-0.87
-12.64%
2024-08-08
415.48M
0.99
1.64
-39.63%
2024-05-10
93.86M
-1.05
-1.04
0.96%
2024-02-28
291.34M
-1.44
-0.49
193.88%
2023-11-09
22.06M
-1.26
-1.82
-30.77%
2023-08-08
424.43M
0.58
-1.39
-141.73%
2023-05-09
80.95M
-3.41
-3.38
0.89%
2023-02-28
287.83M
-2.28
-0.92
147.83%
2022-11-08
734.58M
-2.15
2.21
-197.29%
2022-08-08
185.93M
-6.53
5.51
-218.51%
2022-05-09
703.97M
2.56
2.69
-4.83%
2022-02-28
222.2M
-11.18
-1.43
681.82%
2021-11-04
178.84M
-4.31
-4.04
6.68%
2021-08-05
298.02M
-4.75
-3.76
26.33%
2021-05-10
447.23M
-3.05
-2.65
15.09%
2021-03-01
279.66M
-2.7
-1.53
76.47%
2020-11-09
157.02M
-3.21
2.36
-236.02%
2020-08-10
35.54M
-0.3
-0.57
-47.37%
2020-05-11
3.38M
-0.58
-0.67
-13.43%
2020-03-11
8.82M
-1.13
-1.08
4.63%
2019-11-07
2.51M
-1.03
-1.02
0.98%
2019-08-07
3.36M
-1.69
-1.61
4.97%
2019-05-02
3.98M
-2.2
-2.4
-8.33%
2019-03-18
6.13M
-2.6
-2.4
8.33%
2018-11-07
7.74M
-2.4
-2.4
0.00%
2018-08-08
10.77M
-2.4
-2.4
0.00%
2018-05-09
9.65M
-2.8
-2.8
0.00%
2018-03-14
10.41M
-3.2
-3
6.67%
2017-11-07
8.35M
-3
-3.2
-6.25%
2017-08-08
6.73M
-3.2
-3.2
0.00%
2017-05-08
5.68M
-3.2
-3.6
-11.11%
2017-02-27
5.4M
-4.2
-4.6
-8.70%
2016-11-09
3.23M
-4.8
-5.4
-11.11%
2016-08-09
2.5M
-5.8
-5.2
11.54%
2016-05-04
4.22M
-5.8
-5.4
7.41%
2016-02-29
5.85M
-5.8
-3
93.33%
2015-11-09
6.53M
-2.4
-2
20.00%
2015-08-10
14M
-1.6
-1.8
-11.11%
2015-05-07
9.88M
-2
-2.2
-9.09%
2015-02-26
6.72M
-2.6
-1.8
44.44%
2014-11-05
8.21M
-1.6
-1.6
0.00%
2014-08-06
8.26M
-1.6
-1.4
14.29%
2014-05-07
7.46M
-1.4
-1.4
0.00%
2014-03-10
8.75M
-1.4
-1.6
-12.50%
2013-11-07
4.8M
-1.8
-1.2
50.00%
2013-08-08
3.53M
-1.6
-1
60.00%
2013-05-07
3.83M
-1.4
-0.8
75.00%
2013-03-01
4.57M
-1.4
-0.8
75.00%
2012-11-02
5.76M
-1
-0.8
25.00%
2012-08-03
7.1M
-1
-0.96
4.17%
2012-05-04
4.64M
-1.2
-0.76
57.89%
2012-03-09
5.84M
-0.6
-0.77
-22.08%
2011-11-04
5.01M
-0.6
-0.97
-38.14%
2011-08-05
3M
-0.6
-1.4
-57.14%
2011-05-10
834k
-1.4
-1.35
3.70%
2011-03-28
51k
-1.2
-1.72
-30.23%
2010-11-05
175k
-2
-1.77
12.99%
2010-08-06
7k
-1.8
-2.03
-11.33%
2010-05-10
110k
-2.2
-2.48
-11.29%
